Gilead Sciences reported $6.26B in Sales Revenues for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 14583M 1045M
Acorda Therapeutics ACOR:US $ 31.05M 8.52M
Agios Pharmaceuticals AGIO:US $ 5.58M 4.75M
ALKERMES ALKS:US $ 276.22M 2.33M
Alnylam Pharmaceuticals ALNY:US $ 224.82M 11.56M
Amgen AMGN:US $ 6594M 356M
Biogen BIIB:US $ 2589.1M 57.3M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
Bluebird Bio BLUE:US $ 1.52M 0.43M
Bristol Myers Squibb BMY:US $ 11887M 239M
Coherus Biosciences CHRS:US $ 60.15M 0.04M
Eli Lilly And LLY:US $ 6488M 1322M
Gilead Sciences GILD:US $ 6260M 330M
GlaxoSmithKline GSK:LN 6929M 2851M
Glaxosmithkline GSK:US $ 6929M 2851M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
Johnson & Johnson JNJ:US $ 24020M 594M
Merk MRK:US $ 14593M 1308M
Moderna Inc MRNA:US 4.75B 1.32B
Neurocrine Biosciences NBIX:US $ 378.2M 67.6M
Novartis NOVN:VX SF 13085M 271M
Pfizer PFE:US $ 27742M 2081M
Ptc Therapeutics PTCT:US $ 165.53M 16.79M
Puma Biotechnology PBYI:US $ 59.52M 13.78M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Sangamo Biosciences SGMO:US $ 29.38M 1.15M
Sarepta Therapeutics SRPT:US $ 233.49M 22.66M
Teva Pharmaceutical Industries TEVA:US $ 3786M 125M
United Therapeutics UTHR:US $ 466.9M 5M
Vertex Pharmaceuticals VRTX:US $ 2196.2M 98.7M
YTE INCY:US $ 911.4M 178.16M